MSc Experimental Medicine

In this MSc program the students will be exposed to theoretical and practical training of Experimental Medicine skills giving a great emphasis towards clinical translation. The modules will focus on State-Of-The-Art Experimental Medicine Skills on the research and clinical translation related to vascular, respiratory and infection/immunity related diseases, which will be linked to a full spectrum of research projects based on translational experimental medicine covered from animal and human models of disease through to the design and implementation of clinical trials.
Experimental Medicine also aims to identify mechanisms of pathophysiology of disease, and demonstrate proof-of-concept evidence of the efficacy and importance of new discoveries or treatments. It spans fundamental research in the biosciences to the application of new strategies towards clinical translation that will improve delivery of healthcare. There is an increasing need for graduates who can undertake basic and clinical research and translate it into improved medical treatments for patients. This research-intensive MSc programme in Experimental Medicine will equip the students with the rigorous research skills, and the innovative mentality to tackle the major medical and therapeutic challenges of the 21st century.
The MSc in Experimental Medicine is designed for students wishing to pursue a career in experimental medicine, whether it is in academia, clinical practice, industry, or government. The programme will also provide an excellent platform for progression to PhD programmes either in Queen’s or worldwide.
The MSc in Experimental Medicine will develop a strong fundamental understanding of high-quality biomedical research, including experimental design and execution, data management and interpretation, and scientific communication, including publishing, presentation, and use of social media.
The programme offers comprehensive research training with access to over 60 research groups and the state-of-the-art research facilities at the Wellcome Wolfson Institute of Experimental Medicine (WWIEM). Research facilities include Central Technology Units for Imaging and Genomics which are leading the way in research excellence and innovative healthcare.
Applicants are advised to apply as early as possible and ideally no later than 31st July 2024 for courses which commence in late September. In the event that any programme receives a high number of applications, the University reserves the right to close the application portal. Notifications to this effect will appear on the Direct Application Portal against the programme application page.
Please note a deposit will be required to guarantee a place on the course. Due to high demand, applications may not be considered if the course has reached its maximum class size and will be placed on a waiting list. Please see deposit terms and conditions for more details.